Clinica Ostetrica Ginecologica, Dipartimento Ostetrico Ginecologico, Fondazione IRCCS Policlinico, Ospedale Maggiore, Mangiagalli, Regina Elena, Università degli Studi di Milano, Milan, Italy.
Menopause. 2010 Sep-Oct;17(5):1080-6. doi: 10.1097/gme.0b013e3181dd05a9.
Several randomized controlled trials (RCTs) have examined the role of soy isoflavones on cardiovascular risk factors in perimenopausal and postmenopausal women and have yielded inconsistent results. This meta-analysis aimed to assess the overall effect of soy isoflavones on glucose metabolism: fasting blood glucose, insulin, and insulin resistance.
We searched for all articles published in English and indexed in Medline from January 1990 to December 2009. We included RCTs for soy isoflavone supplementation in perimenopausal and postmenopausal women not taking hormone therapy, selecting non-Asian women only. The main outcomes were fasting blood glucose changes from baseline.
We identified 10 eligible RCTs containing blood glucose data of 794 women. The main result was that soy isoflavones did not affect fasting blood glucose significantly. Under a random-effects model, the average difference in fasting blood glucose values between women assigned to isoflavones and women assigned to placebo was -2.16 mg/dL (95% CI, -5.21 to 0.89 mg/dL; P = 0.17). In genistein studies, the mean difference was -7.15 mg/dL (95% CI, -11.47 to -2.82). However, the effects on insulin and homeostasis model assessment insulin resistance were significant: -1.37 microIU/mL (95% CI, -1.92 to -0.81 microIU/mL) and -0.39 (95% CI, -0.65 to -0.14), respectively. Subgroup analyses did not show a significant effect of isoflavone dose, whereas isoflavone mixtures and genistein had a different effect on fasting blood glucose.
This meta-analysis of RCTs showed that isoflavone use was not associated with a significant glycemia reduction in perimenopausal and postmenopausal non-Asian women. However, the few studies that reported insulin and homeostasis model assessment insulin resistance changes suggested that soy isoflavones and genistein alone had a beneficial effect on glucose metabolism.
几项随机对照试验(RCT)已经研究了大豆异黄酮对围绝经期和绝经后妇女心血管危险因素的作用,但其结果不一致。本荟萃分析旨在评估大豆异黄酮对葡萄糖代谢的总体影响:空腹血糖、胰岛素和胰岛素抵抗。
我们检索了 1990 年 1 月至 2009 年 12 月期间以英文发表并被 Medline 索引的所有文章。我们纳入了在不接受激素治疗的围绝经期和绝经后妇女中进行大豆异黄酮补充的 RCT,仅选择非亚洲妇女。主要结局是空腹血糖从基线的变化。
我们确定了 10 项符合条件的 RCT,其中包含 794 名妇女的血糖数据。主要结果是大豆异黄酮对空腹血糖没有显著影响。在随机效应模型下,分配给异黄酮的妇女与分配给安慰剂的妇女的空腹血糖值的平均差异为-2.16mg/dL(95%CI,-5.21 至 0.89mg/dL;P=0.17)。在染料木黄酮研究中,平均差异为-7.15mg/dL(95%CI,-11.47 至-2.82)。然而,对胰岛素和稳态模型评估胰岛素抵抗的影响是显著的:-1.37μIU/mL(95%CI,-1.92 至-0.81μIU/mL)和-0.39(95%CI,-0.65 至-0.14)。亚组分析表明,异黄酮剂量没有显著效果,而异黄酮混合物和染料木黄酮对空腹血糖有不同的影响。
本 RCT 荟萃分析显示,大豆异黄酮的使用与围绝经期和绝经后非亚洲妇女的血糖降低无关。然而,少数报告胰岛素和稳态模型评估胰岛素抵抗变化的研究表明,大豆异黄酮和染料木黄酮单独对葡萄糖代谢有有益影响。